This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Jackson Laboratory. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Saman Farahmand: Innovator in Cancer Classification Technology
Introduction
Saman Farahmand is an accomplished inventor based in Quincy, MA, specializing in advanced technologies for cancer classification. He holds a patent that leverages deep learning models to enhance the accuracy of histopathological image analysis. His work is pivotal in the field of medical diagnostics, particularly in identifying cancerous tissues.
Latest Patents
Farahmand's notable patent is titled "Convolutional neural networks for classification of cancer histological images." This patent describes techniques for classifying histopathological whole slide images (WSIs) as either cancerous or non-cancerous. The deep learning model he developed is capable of processing these images to determine the presence of genetic mutations in cancerous tissues. The system includes a processor designed to implement a container-based processing architecture, which is essential for training and utilizing the deep learning model effectively. Furthermore, the classification results obtained from this model can inform treatment decisions for patients.
Career Highlights
Saman Farahmand is currently employed at The Jackson Laboratory, a renowned research institution dedicated to advancing human health through genetics. His role involves applying his expertise in deep learning and image classification to improve cancer diagnostics. His innovative approach has the potential to significantly impact patient outcomes by enabling more precise treatment options.
Collaborations
Farahmand collaborates with esteemed colleagues, including Jeffrey Hsu-Min Chuang and Javad Noorbakhsh. Their combined expertise contributes to the advancement of research in cancer classification and treatment methodologies.
Conclusion
Saman Farahmand's contributions to the field of cancer diagnostics through his innovative patent and collaborative efforts at The Jackson Laboratory highlight the importance of technology in improving healthcare outcomes. His work exemplifies the intersection of artificial intelligence and medical research, paving the way for future advancements in cancer treatment.